Control of transcription termination: a rho-dependent termination site in bacteriophage lambda.

Interactions of bacteriophage and host macromolecules in the growth of bacteriophage lambda. Microbiol Rev (1984) 4.17

Termination factor Rho and its cofactors NusA and NusG silence foreign DNA in E. coli. Science (2008) 2.66

Promoter for the establishment of repressor synthesis in bacteriophage lambda. Proc Natl Acad Sci U S A (1980) 2.23

Termination efficiency at rho-dependent terminators depends on kinetic coupling between RNA polymerase and rho. Proc Natl Acad Sci U S A (1992) 2.01

Rho-dependent transcription termination in the tryptophanase operon leader region of Escherichia coli K-12. J Bacteriol (1986) 1.70

Posttranscriptional control of Klebsiella pneumoniae nif mRNA stability by the nifL product. J Bacteriol (1986) 1.55

RNA sequence and secondary structure requirements for rho-dependent transcription termination. Nucleic Acids Res (1985) 1.48

Transcription terminates at lambda tR1 in three clusters. Proc Natl Acad Sci U S A (1982) 1.42

Control of Klebsiella pneumoniae nif mRNA synthesis. J Bacteriol (1985) 1.24

In vitro regulation of phage lambda cII gene expression by Escherichia coli integration host factor. Proc Natl Acad Sci U S A (1984) 1.19

lambda mutation in the Escherichia coli rho gene that inhibits the N protein activity of phage lambda. Proc Natl Acad Sci U S A (1983) 1.08

The DNA sequence of the phage lambda genome between PL and the gene bet. Nucleic Acids Res (1981) 0.99

Construction and use of lambda PL promoter vectors for direct cloning and high level expression of PCR amplified DNA coding sequences. Nucleic Acids Res (1992) 0.98

Cross-specificities between cII-like proteins and pRE-like promoters of lambdoid bacteriophages. Genetics (1987) 0.91

Analysis of mutations in the ninR region of bacteriophage lambda that bypass a requirement for lambda N antitermination. J Bacteriol (1990) 0.90

nusA amber mutation that causes temperature-sensitive growth of Escherichia coli. J Bacteriol (1988) 0.88

Single-gene deletion mutants of Escherichia coli with altered sensitivity to bicyclomycin, an inhibitor of transcription termination factor Rho. J Bacteriol (2011) 0.88

Transcription termination signals in the nin region of bacteriophage lambda: identification of Rho-dependent termination regions. Genetics (1995) 0.87

Analysis of transcription termination signals in the nin region of bacteriophage lambda: the roc deletion. J Bacteriol (1988) 0.87

Little lambda, who made thee? Microbiol Mol Biol Rev (2004) 0.86

Mutations that affect the efficiency of translation of mRNA for the cII gene of coliphage lambda. Genetics (1987) 0.83

Escherichia coli-Salmonella typhimurium hybrid nusA genes: identification of a short motif required for action of the lambda N transcription antitermination protein. J Bacteriol (1994) 0.82

Phage HK022 Nun protein represses translation of phage lambda N (transcription termination/translation repression). Proc Natl Acad Sci U S A (2003) 0.80

Suppression of factor-dependent transcription termination by antiterminator RNA. J Bacteriol (2003) 0.77

Localisation and characterization of a new rho-dependent transcription terminator from bacteriophage T5. Nucleic Acids Res (1985) 0.75

Evidence that the promoter can influence assembly of antitermination complexes at downstream RNA sites. J Bacteriol (2006) 0.75

Regulatory sequences involved in the promotion and termination of RNA transcription. Annu Rev Genet (1979) 54.83

A system to study promoter and terminator signals recognized by Escherichia coli RNA polymerase. Gene Amplif Anal (1981) 8.21

Cardiomegaly in an Infant: Idiopathic. Proc R Soc Med (1939) 5.47

Identification of critical staphylococcal genes using conditional phenotypes generated by antisense RNA. Science (2001) 5.40

The relationship between function and DNA sequence in an intercistronic regulatory region in phage lambda. Nature (1978) 5.38

Diverse spermatogenic defects in humans caused by Y chromosome deletions encompassing a novel RNA-binding protein gene. Nat Genet (1995) 5.02

Isolation and characterization of conditional lethal mutants of Escherichia coli defective in transcription termination factor rho. Proc Natl Acad Sci U S A (1976) 4.93

Crystal structure of an HIV-binding recombinant fragment of human CD4. Nature (1990) 4.81

The product of ras is a GTPase and the T24 oncogenic mutant is deficient in this activity. Nature (1984) 4.61

Purified lambda regulatory protein cII positively activates promoters for lysogenic development. Nature (1981) 4.60

Termination of transcription in E. coli. Cell (1983) 4.42

Efficient expression of Escherichia coli galactokinase gene in mammalian cells. Proc Natl Acad Sci U S A (1982) 4.25

Ferritin: a cytoprotective antioxidant strategem of endothelium. J Biol Chem (1992) 4.22

Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med (1977) 4.14

Efficient translation of prokaryotic mRNAs in a eukaryotic cell-free system requires addition of a cap structure. Nature (1979) 4.11

Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial. J Clin Oncol (2001) 4.09

The use of pKc30 and its derivatives for controlled expression of genes. Methods Enzymol (1983) 3.90

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J Biol Chem (1998) 3.88

Microinjection of the oncogene form of the human H-ras (T-24) protein results in rapid proliferation of quiescent cells. Cell (1984) 3.81

Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the gag precursor. Proc Natl Acad Sci U S A (1987) 3.72

Termination of transcription in bacteriophage lambda. Heterogeneous, 3'-terminal oligo-adenylate additions and the effects of rho factor. J Biol Chem (1975) 3.71

Surveillance and prevention of residential-fire injuries. N Engl J Med (1996) 3.60

Translational coupling at an intercistronic boundary of the Escherichia coli galactose operon. Cell (1982) 3.56

Tissue-specific and differentiation-specific expression of a human K14 keratin gene in transgenic mice. Proc Natl Acad Sci U S A (1989) 3.55

A genomic analysis of two-component signal transduction in Streptococcus pneumoniae. Mol Microbiol (2000) 3.50

Highly reiterated sequences of SIMIANSIMIANSIMIANSIMIANSIMIAN. Science (1978) 3.29

Expression and characterization of the human c-myc DNA-binding protein. Mol Cell Biol (1985) 3.24

Constitutive function of a positively regulated promoter reveals new sequences essential for activity. J Biol Chem (1987) 3.23

Role of adherence in growth of Acinetobacter calcoaceticus RAG-1 on hexadecane. J Bacteriol (1981) 2.96

gridlock, an HLH gene required for assembly of the aorta in zebrafish. Science (2000) 2.90

Nucleotide sequence homology at the 3' termini of RNA from vesicular stomatitis virus and its defective interfering particles. Proc Natl Acad Sci U S A (1978) 2.82

Phase III, multicenter, double-blind, randomized study of letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate. J Clin Oncol (2001) 2.81

Sequence of Cro gene of bacteriophage lambda. Nature (1977) 2.78

W mutant mice with mild or severe developmental defects contain distinct point mutations in the kinase domain of the c-kit receptor. Genes Dev (1990) 2.77

Copper metallothionein of yeast, structure of the gene, and regulation of expression. Proc Natl Acad Sci U S A (1984) 2.74

Adherence of Acinetobacter calcoaceticus RAG-1 to human epithelial cells and to hexadecane. Infect Immun (1981) 2.74

Bacterial adherence to polystyrene: a replica method of screening for bacterial hydrophobicity. Appl Environ Microbiol (1981) 2.73

Elevated serum Her-2/neu level predicts decreased response to hormone therapy in metastatic breast cancer. J Clin Oncol (2002) 2.70

E1A 13S and 12S mRNA products made in Escherichia coli both function as nucleus-localized transcription activators but do not directly bind DNA. Mol Cell Biol (1985) 2.68

Mapping of the fabA locus for unsaturated fatty acid biosynthesis in Escherichia coli. J Bacteriol (1972) 2.63

Endocytosis in Chang liver cells. Quantitation by sucrose- 3 H uptake and inhibition by cytochalasin B. J Cell Biol (1971) 2.63

A rho-dependent termination site in the gene coding for tyrosine tRNA su3 of Escherichia coli. Nature (1978) 2.58

Affecting gene expression by altering the length and sequence of the 5' leader. Proc Natl Acad Sci U S A (1984) 2.58

Nucleotide sequence of the operator-promoter region of the galactose operon of Escherichia coli. Proc Natl Acad Sci U S A (1977) 2.57

Microinjected c-myc as a competence factor. Science (1985) 2.56

Evolution of two-component signal transduction. Mol Biol Evol (2000) 2.55

Envelope glycoproteins from biologically diverse isolates of immunodeficiency viruses have widely different affinities for CD4. Proc Natl Acad Sci U S A (1991) 2.54

Identification, evolution, and essentiality of the mevalonate pathway for isopentenyl diphosphate biosynthesis in gram-positive cocci. J Bacteriol (2000) 2.50

Studies of novel transducing variants of lambda: dispensability of genes N and Q. Virology (1969) 2.44

Adenovirus E1a gene product expressed at high levels in Escherichia coli is functional. Science (1984) 2.38

Structure and function of the cy control region of bacteriophage lambda. J Mol Biol (1980) 2.37

A promoter of pBR322 activated by cAMP receptor protein. Nucleic Acids Res (1981) 2.37

An analysis of the processes of infection and induction of E. coli mutant hfl-1 by bacteriophage lambda. Virology (1973) 2.36

Pentapeptide nuclear localization signal in adenovirus E1a. Mol Cell Biol (1987) 2.30

Polyomavirus small t antigen: overproduction in bacteria, purification, and utilization for monoclonal and polyclonal antibody production. J Virol (1986) 2.27

The influence of age, diagnosis, and gender on proper use of metered-dose inhalers. Am J Respir Crit Care Med (1994) 2.23

Promoter for the establishment of repressor synthesis in bacteriophage lambda. Proc Natl Acad Sci U S A (1980) 2.23

Efficient expression of influenza virus NS1 nonstructural proteins in Escherichia coli. Proc Natl Acad Sci U S A (1983) 2.19

A sonographic screening method for Down syndrome. Am J Obstet Gynecol (1987) 2.16

Posttranscriptional control of bacteriophage lambda gene expression from a site distal to the gene. Proc Natl Acad Sci U S A (1982) 2.13

Removal of a terminator structure by RNA processing regulates int gene expression. J Mol Biol (1984) 2.13

Bacteriophage lambda protein cII binds promoters on the opposite face of the DNA helix from RNA polymerase. Nature (1983) 2.13

Nucleotide sequences of the 5' and 3' termini of bacteriophage T7 early messenger RNAs synthesized in vivo: evidence for sequence specificity in RNA processing. J Mol Biol (1974) 2.10

Induction of the heat shock response of E. coli through stabilization of sigma 32 by the phage lambda cIII protein. Genes Dev (1987) 2.07

Interaction between FKBP12-rapamycin and TOR involves a conserved serine residue. J Biol Chem (1994) 2.04

The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air. N Engl J Med (1990) 2.03

Delta-aminolevulinic acid-requiring mutant from Escherichia coli. J Bacteriol (1967) 1.98

The expression in yeast of the Escherichia coli galK gene on CYC1::galK fusion plasmids. Gene (1983) 1.98

Characterization of short tandem repeats from thirty-one human telomeres. Genome Res (1997) 1.96

Functions of purified E1A protein microinjected into mammalian cells. Proc Natl Acad Sci U S A (1984) 1.92

Synthesis of the complete trans-activation gene product of human T-lymphotropic virus type III in Escherichia coli: demonstration of immunogenicity in vivo and expression in vitro. Proc Natl Acad Sci U S A (1986) 1.90

Regulated antisense RNA eliminates alpha-toxin virulence in Staphylococcus aureus infection. J Bacteriol (1999) 1.88

Differential translation efficiency explains discoordinate expression of the galactose operon. Cell (1981) 1.87

Microarray-based identification of htrA, a Streptococcus pneumoniae gene that is regulated by the CiaRH two-component system and contributes to nasopharyngeal colonization. Infect Immun (2002) 1.87

Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry. Pediatr Res (2000) 1.86

Activation of human immunodeficiency virus type 1 by DNA damage in human cells. Nature (1988) 1.85

The 289-amino acid E1A protein of adenovirus binds zinc in a region that is important for trans-activation. Proc Natl Acad Sci U S A (1988) 1.84

Two promoters, one inducible and one constitutive, control transcription of the Streptomyces lividans galactose operon. Proc Natl Acad Sci U S A (1987) 1.79

The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma. J Immunol (1998) 1.78

Transcription of the sulA gene and repression by LexA. J Mol Biol (1983) 1.78

Purification and characterization of human H-ras proteins expressed in Escherichia coli. Mol Cell Biol (1985) 1.77

Impaired nuclear transport of a human variant tRNAiMet. Nature (1982) 1.75

Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer. Gut (1999) 1.75

Serum HER-2/neu and response to the aromatase inhibitor letrozole versus tamoxifen. J Clin Oncol (2003) 1.72

Inhibition of bacterial adherence to hydrocarbons and epithelial cells by emulsan. Infect Immun (1983) 1.71

Trimellitic anhydride-induced airway syndromes: clinical and immunologic studies. J Allergy Clin Immunol (1977) 1.71